enVVeno Medical (NVNO) Other financing activities (2019 - 2024)

enVVeno Medical has reported Other financing activities for 5 years, with the latest figure at $1.0 million in Q2 2024.

• For the quarter ending Q2 2024, Other financing activities fell 13.14% year-over-year to $1.0 million; the trailing twelve-month figure through Jun 2024 stood at $4.4 million (down 40.96% YoY), and the FY2023 full-year result was $5.2 million, down 42.23% from the prior year.
• Other financing activities for Q2 2024 stood at $1.0 million, down from $1.1 million in the prior quarter.
• The five-year high for Other financing activities was $2.3 million in Q2 2022, with the low at $79658.0 in Q1 2020.
• Average Other financing activities over 4 years is $1.3 million, with a median of $1.1 million recorded in 2023.
• Year-over-year, Other financing activities plunged 79.4% in 2020 and fell 13.14% in 2024.
• Tracing NVNO's Other financing activities over 4 years: stood at $360026.0 in 2020, then surged by 521.62% to $2.2 million in 2022, then plunged by 48.93% to $1.1 million in 2023, then decreased by 12.07% to $1.0 million in 2024.
• The last three Other financing activities figures came in at $1.0 million (Q2 2024), $1.1 million (Q1 2024), and $1.1 million (Q4 2023), per Business Quant data.

Peer Comparison